Stopping gabapentin abruptly can trigger withdrawal symptoms that begin within one to two days, and in rare cases the consequences include seizures serious enough to require emergency care. The short answer is no, you should not quit gabapentin cold turkey. The drug changes how your nervous system handles excitatory signaling, and when it disappears suddenly, your brain can rebound in ways that range from deeply uncomfortable to dangerous. A supervised taper is the standard medical recommendation, though the pace and duration of that taper vary more widely than most people expect.
What Withdrawal Actually Looks and Feels Like
Gabapentin withdrawal shares a surprising amount of overlap with alcohol and benzodiazepine withdrawal. Reported symptoms include anxiety, sweating, rapid heartbeat, insomnia, tremors, restlessness, and irritability. In more pronounced cases, people describe hallucinations, delirium, cold sweats, body aches, chest tightness, loss of appetite, diarrhea, and depression. Some people also report a flu-like constellation of symptoms: chills, aching joints, general malaise.
These symptoms tend to start showing up within 12 to 48 hours after the last dose. How intense they become depends on several factors, including how long you have been taking gabapentin, what dose you were on, and whether you have a history of substance use or other neurological conditions. The resemblance to alcohol and benzodiazepine withdrawal is not a coincidence; researchers believe it reflects a shared downstream effect on the brain’s inhibitory and excitatory balance.
Why Your Nervous System Reacts This Way
Gabapentin is structurally similar to GABA, one of the brain’s main calming neurotransmitters, but it does not actually attach to GABA receptors the way a benzodiazepine does. Instead, it binds to a specific part of voltage-gated calcium channels on nerve cells, called the alpha-2/delta subunit. By latching onto that subunit, gabapentin dials down the release of several excitatory chemical messengers, including glutamate, norepinephrine, and dopamine.
Over time, your nervous system adjusts to this dampened state. Neurons compensate by becoming more sensitive or by producing more excitatory signals to maintain normal function. When gabapentin is suddenly removed, those compensatory changes are still in place but the brake is gone, and the result is a surge of excitatory activity the brain is not equipped to handle. The effect is chronic rather than instant: research shows that gabapentin’s inhibition of calcium currents builds over sustained exposure, not from a single dose, which helps explain why withdrawal severity scales with how long someone has been on the drug.
The Worst-Case Scenario Is Seizures
For most people, gabapentin withdrawal is miserable but not life-threatening. The serious exception is seizures. In one documented case, a man who ran out of his gabapentin prescription and went two days without it arrived at an emergency department in status epilepticus, a state of prolonged, continuous seizure activity that can cause brain damage or death. He had no prior history of a seizure disorder and was not taking any other medications. A full medical workup found no other explanation for his seizures.
That case is particularly striking because gabapentin is often prescribed specifically to prevent seizures in people with epilepsy. If you are taking it for seizure control, stopping abruptly carries a double risk: not only can withdrawal itself provoke seizures, but the underlying seizure disorder you were treating is now uncontrolled. Even if you take gabapentin for pain, anxiety, or another off-label reason and have never had a seizure in your life, the withdrawal-induced excitatory rebound can still push your brain past the seizure threshold.
Even a Short Taper Is Not Always Enough
A common assumption is that a one-week taper should be sufficient. That is not always the case. One published report describes a geriatric patient who developed debilitating withdrawal symptoms despite having undergone a gradual, week-long taper. The authors concluded that gabapentin tapering should follow a course more like a benzodiazepine taper, meaning slowly and over a period of weeks to months rather than days.
Age seems to matter. Older adults may be more sensitive to withdrawal, possibly because kidney function declines with age and gabapentin is cleared almost entirely through the kidneys rather than the liver. A slower clearance rate means the drug lingers longer at steady state, and the nervous system may become more deeply adapted to its presence. That said, younger adults are not immune; the early case reports of gabapentin withdrawal largely involved young to middle-aged patients.
When Tapering Takes Months
Perhaps the most striking illustration of how variable gabapentin discontinuation can be is a published case of a patient with alcohol use disorder whose gabapentin taper took 18 months to complete. After an accidental pause in her medication revealed that she could not tolerate withdrawal, her care team initiated a very slow dose reduction. She decreased her daily dose by about 100 mg per month until she reached 300 mg. At that point the taper slowed further, down to 20 to 30 mg decrements per month. For the final 100 mg, she tapered by just 5 mg every one to two weeks, eventually discontinuing at 60 mg.
That pace sounds extreme, and for most people it would be. But it reflects a real phenomenon: some individuals develop a level of physical dependence on gabapentin that makes even modest reductions feel intolerable. Factors like higher doses, longer duration of use, concurrent substance use disorders, and individual neurochemistry all play into how aggressively or gently someone needs to taper. There is no universal schedule, and anyone who tells you “just cut your dose in half for a week and then stop” is oversimplifying.
Who Faces the Highest Risk
Not everyone who stops gabapentin will experience significant withdrawal. Several factors raise the likelihood and severity:
- Higher doses: People taking gabapentin at supratherapeutic levels, whether prescribed or misused, tend to develop withdrawal effects more quickly and intensely.
- Longer use: Months or years of daily use gives the nervous system more time to recalibrate around the drug’s presence.
- History of substance use: People with a history of alcohol, benzodiazepine, or opioid use disorders appear to be more vulnerable to gabapentin dependence and withdrawal.
- Older age: Reduced kidney clearance and greater neurological sensitivity can amplify withdrawal effects.
- Abrupt cessation versus taper: The single biggest modifiable risk factor. A gradual reduction gives the brain time to readjust.
Withdrawal and dependence continue to be reported especially when gabapentin has been misused at doses above what is typically prescribed. Among patients misusing the related drug pregabalin, nearly half reported experiencing withdrawal, and more than a quarter had tried unsuccessfully to quit on their own. While pregabalin is a different medication, it works through the same calcium-channel mechanism, and the withdrawal profiles overlap substantially.
Gabapentin and Opioids Together Add a Separate Layer of Danger
A significant number of people taking gabapentin are also taking opioids, either for pain management or as part of opioid maintenance therapy. This combination introduces a risk that goes beyond withdrawal: respiratory depression. A large population study spanning more than 16 years found that roughly 8% of opioid recipients were co-prescribed gabapentin, and that co-prescription was associated with about a 50% increase in the risk of dying from opioid-related causes. At very high co-prescribed gabapentin doses, the risk nearly doubled.
The mechanism behind this is both pharmacodynamic and pharmacokinetic. Gabapentin and opioids both depress respiratory drive, and their effects add up. On top of that, opioid use can increase gabapentin concentrations in the blood, compounding the effect. Experimental research suggests that even a single dose of a gabapentinoid can reverse the respiratory tolerance that chronic opioid users have built up, making a previously tolerated opioid dose suddenly dangerous.
If you are on both gabapentin and an opioid and want to stop one of them, the order and pace of discontinuation matters. This is not a situation to navigate alone. Stopping gabapentin abruptly while continuing an opioid, or vice versa, can shift the pharmacological balance in unpredictable ways. Your prescriber needs to be involved.
Pregnancy and Newborn Withdrawal
Gabapentin crosses the placenta, and newborns exposed to it during pregnancy can develop withdrawal symptoms after birth. Case reports describe neonatal gabapentin withdrawal syndrome in infants whose mothers took the drug throughout pregnancy. A large cohort study found that among neonates exposed in utero to prescription opioids, adding gabapentin to the mix raised the risk of neonatal drug withdrawal by about 60% compared to opioid exposure alone. The absolute risk of neonatal withdrawal climbed to roughly 11% when gabapentin and opioids were combined in utero, versus 1% with opioids alone.
For pregnant women taking gabapentin, the decision about whether and how to discontinue is complicated. Stopping abruptly could trigger maternal withdrawal, including seizures, which pose their own risks to the pregnancy. A slow taper under close obstetric and neurological supervision is typically the approach, but the timeline and safety calculus differ from case to case. If you are pregnant or planning to become pregnant while on gabapentin, this conversation with your doctor should happen as early as possible.
Why So Many People Are in This Situation
Gabapentin is one of the most commonly prescribed medications in the United States, and a large share of those prescriptions are for off-label uses, meaning conditions the drug was not originally approved to treat. It is FDA-approved for epilepsy and postherpetic neuralgia (the nerve pain that follows shingles), but doctors prescribe it widely for general neuropathic pain, fibromyalgia, migraines, anxiety disorders, insomnia, and as an alternative to opioids for chronic pain management. Some of those off-label uses are supported by reasonable evidence; others rest on modest or inconclusive data.
The rise in off-label gabapentin prescribing has been partly driven by the opioid crisis. As clinicians looked for non-opioid options for pain, gabapentin was seen as a safer alternative. And in many respects it is. It does not carry the same overdose risk as opioids when used alone, it is not hepatically metabolized (so liver interactions are minimal), and its side-effect profile at standard doses is generally tolerable. But the perception that gabapentin is essentially harmless has led to a situation where many people are put on it without a clear discussion of what stopping it will involve. A drug that was once considered to have negligible dependence potential is now recognized as one that can produce real, sometimes severe, physical dependence.
What a Safe Taper Looks Like in Practice
There is no single tapering protocol that works for everyone, but some general principles apply. Most clinicians aim to reduce the daily dose by no more than 10 to 25% at a time, with each reduction held steady for one to two weeks before making the next cut. For someone on a moderate dose taken for a few months, a taper over four to eight weeks may be adequate. For someone on a high dose for years, or someone with a history of difficult withdrawals, the process can stretch much longer.
Tapering often gets harder toward the end. People who tolerate the early reductions well sometimes hit a wall at lower doses, likely because the relative change in brain exposure becomes proportionally larger as the absolute dose shrinks. Dropping from 1,800 mg to 1,500 mg is a roughly 17% cut; dropping from 300 mg to 100 mg is a 67% cut. Some tapering frameworks account for this by using smaller absolute reductions as the dose decreases, which is what happened in the 18-month taper case where the patient shifted from 100 mg monthly reductions down to 5 mg reductions in the final stretch.
During a taper, some people experience mild withdrawal symptoms at each step that resolve within a few days. Others may need to pause at a given dose for longer, or even step back up temporarily before trying again. If you are experiencing significant symptoms during a taper, the answer is usually to slow down rather than to power through. Withdrawal is not a character test. It is a neurochemical process, and the speed at which your particular nervous system can readjust is not something you can will into being faster.
Gabapentin Misuse and Changing Regulatory Attitudes
Gabapentin was not originally classified as a controlled substance at the federal level in the United States, and in most states it still is not. But a growing number of states have moved to schedule it or add it to prescription drug monitoring programs, reflecting accumulating evidence that it carries dependence and misuse potential. Several states now classify gabapentin as a Schedule V controlled substance, the lowest tier of federal scheduling.
The misuse picture often involves gabapentin being taken at doses well above what is prescribed, sometimes to enhance the effects of opioids or to produce a mild euphoric or sedating effect on its own. The dopamine reward system may play a role in this; research suggests that gabapentin’s downstream effects on dopamine release could contribute to its abuse and addiction potential in susceptible individuals. People who misuse gabapentin at high doses face a steeper withdrawal curve, and the symptoms can develop more rapidly.
Increasing evidence has emerged that gabapentin may not be as benign as once assumed, particularly in the context of substance use disorders. Reviews of its off-label uses for conditions like migraines, fibromyalgia, and mental illness have found modest to no benefit for several of these indications. For some patients, this means they are taking a medication that provides marginal therapeutic benefit while creating a real dependence liability, which makes the question of how to stop it all the more pressing.